Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis
NCT ID: NCT03178838
Last Updated: 2017-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2013-12-03
2014-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Other microorganismes such as virures, yeasts and protozoans could potentially impact the emergence and development of periodontal diseases. The presence of protozoans in periodontitis have been investigated in this study.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consulting in periodontal department of CHU, Nancy
* Patient with moderate to severe periodontitis
* At least 2 periodontal sites with PPD≥ 4mm and One healthy site
* No scaling root planning in the last 6 months
* Patients insured under the French social security system
Exclusion Criteria
* Patients with antibiotic therapy, and/or all medecines which could modify the buccal microbiota in the last 6 months
* Tooth with endodontic periapical lesion
* Patients having a scaling root planning in the last 6 months
* Patient with guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine BISSON, PhD
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy / Université de Lorraine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSS2016/PARO-PROTO-BISSON/VS
Identifier Type: -
Identifier Source: org_study_id